NCT02791672

Brief Summary

The pedicled latissimus dorsi flap is a piece of tissue taken from the back that is used to reconstruct the breast after cancerous tissue is removed. Over the years, improvements in surgical technique and pain control have decreased the length of stay in hospital after this procedure. Recently, early discharge after breast reconstruction using another very similar pedicled flap, called the transverse rectus abdominis flap, was shown to be safe, patient-centered, and associated with significant hospital cost-savings by another Canadian group. With increasing pressure from hospital administrators to weigh financial considerations into treatment decision making, doctors must test cost-saving strategies in order to ensure patient satisfaction and safety. Here, we plan to evaluate patient safety, satisfaction and cost efficacy in breast reconstruction using the pedicled latissimus dorsi myocutaneous flap. We hypothesize that patient care planning can allow for safe and cost-effective same-day discharge and improved patient satisfaction after autologous breast reconstruction using the pedicled latissimus dorsi flap. After nearly 10 successful same-day discharges using this flap, our experience at the Ottawa Hospital suggests that this practice is safe, has increased patient satisfaction scores, decreased narcotic use, no short or long term complications and is more cost effective compared to patients who stay overnight. In the present study, we hope to quantify our results by demonstrating that same day discharge is a cost effective strategy that does not compromise patient safety and satisfaction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 7, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

June 7, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

May 31, 2016

Last Update Submit

June 2, 2016

Conditions

Keywords

Perioperative CareBreast Reconstruction

Outcome Measures

Primary Outcomes (4)

  • Conversion rate (from same-day discharge to in-patient care)

    24 hours

  • Patient Satisfaction using Breast-Q questionnaire and Perioperative Care Patient

    24 hours

  • Pain Score

    24 hours

  • Amount of post-operative (24 hours) narcotic usage

    24 hours

Secondary Outcomes (3)

  • Short and Long term complications

    24 Hours

  • Readmission Rate

    24 Hours

  • Cost Savings

    24 Hours

Study Arms (1)

Same Day Discharge

Following a Latissimus Dorsi flap reconstruction patients will be offered discharge at 24 hours. Patients successfully discharged within 24 hours of their surgery will be included in the cohort group.

Behavioral: Discharge within 24 hours

Interventions

If both the physician and patient have no concerns within 24 hours of a Latissimus Dorsi Flap breast reconstruction the patient will be discharged home and enrolled in the cohort group.

Same Day Discharge

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study population will be females older than 18 years old who undergo breast reconstructive surgery with the Latissimus Dorsi flap.

You may qualify if:

  • All patients who undergo breast reconstruction using the latissimus dorsi myocutaneous flap.

You may not qualify if:

  • All patients undergoing breast reconstruction without the latissimus dorsi flap.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Michael J Stein, MD

CONTACT

Jing Zhang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Plastic Surgeon

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 7, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

June 7, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will share

Individual participant data will not be made available. Anonymity will be maintained for all published data.